Clinical Trial: A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies
Study Status: Completed
Recruit Status: RECRUITING
Condition: Relapsed/Refractory Aggressive B-Cell Malignancies
Study Type: INTERVENTIONAL
Official Title: Phase 1/2 Multi-Center Study to Evaluate the Safety and Efficacy of ONCT-808 in Adult Subjects With Relapsed or Refractory Aggressive B-Cell Malignancies
Brief Summary:
This is a Phase 1/2 study to investigate the safety and efficacy of the CAR-T therapy, ONCT-808, in patients with relapsed/refractory (R/R) aggressive B cell malignancies.
Read more